Oxurion Unveils Software-Driven Growth Strategy with Exagis

Oxurion, based in Leuven, Belgium, has announced a new strategy focused on software growth through its clinical research platform, Exagis. Originally an internal eCRF tool, Exagis now serves as a broader Clinical Data Management System, aiding over 25 clinical projects and contributing to 16,000 patients, 600 clinical sites, and 18 sponsors. The platform's commercial use marks a significant shift towards a technology-oriented business model for Oxurion.

Exagis is designed to handle the complexities of modern clinical studies, evolving from mere data collection to a vital software system. Its success stems from real-world clinical operations, shaping its usability, regulatory compliance, and efficiency. Exagis continually builds operational intelligence, enhancing decision-making, automation, and efficiency.

A future milestone for Exagis is the introduction of an electronic Trial Master File module, slated for July 2026. This module will enhance clinical trial documentation management, paving the way for Exagis to expand into a modular eClinical software platform.

Ultimately, Exagis aims to be Oxurion's technological backbone, fostering operational standardization and synergies, while boosting technology-driven revenue. Oxurion's strategy includes integrating artificial intelligence to further optimize operational processes.